SEC Filing Summary: AspenBio, Inc. (Form 8-K)
Business Context and Reporting Period
This Form 8-K was filed by AspenBio, Inc. on September 2, 2005. The report discloses the termination of a material definitive agreement. Note: The request metadata referenced "Riot Platforms, Inc.", but the source text explicitly identifies the registrant as AspenBio, Inc.
Key Financial Metrics
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or margins. However, it discloses specific financial obligations related to the terminated agreement:
- Outstanding Note Balance: Approximately $726,000 owed by the Company to Roger Hurst.
- Repayment Terms: $10,000 per month in principal and interest.
- Termination Costs: The Company has no remaining financial obligations under the terminated Employment Agreement.
Material Changes
On September 2, 2005, the Company terminated the Employment Agreement dated August 30, 2004 (as amended) with Roger Hurst. The termination was effective immediately under Section 5.1.4 of the Agreement.
Outlook, Risks, and Unusual Items
Unusual Items: The filing highlights a significant change in executive compensation structure and a specific debt obligation to a former executive. As of the termination date, Mr. Hurst owned approximately 2,005,000 shares of the Company's common stock. The filing contains no forward-looking guidance or management commentary regarding future operations.
Investor Verification Checklist
- Verify the current status of the $726,000 note payable to Roger Hurst and whether payments are current.
- Confirm the impact of Mr. Hurst's departure on the Company's operations, given his shareholding of ~2,005,000 shares.
- Review subsequent filings to ensure no additional severance or legal costs arose from the termination.
- Clarify the discrepancy between the requested company name (Riot Platforms) and the actual registrant (AspenBio, Inc.).